Product Information
DEXTROAMP-AMPHET ER 30 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.4857 per EA under NDC 00527551537. Its NADAC has been published 280 times since Oct 21, 2020.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 30 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Lannett Company Inc.NDC
00527551537
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037FDA Approved
12/11/2019
TE Code
AB1
On Market Since
12/18/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has been published 280 times since Oct 21, 2020, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4857 per EA |
|---|---|
| All-time high | $0.9501 (Nov 11, 2020) |
| All-time low | $0.3360 (May 22, 2024) |
| 52-week high | $0.5895 |
| 52-week low | $0.4621 |
| Median price | $0.6331 |
| Average price | $0.6285 |
| Largest weekly change | +61.4% (Jun 19, 2024) |
| Weeks tracked | 280 |
| Tracking since | Oct 21, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-17.6%
3Y
-33.0%
5Y
-33.4%
All
-48.9%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 30 MG CAP, manufactured by Lannett Company Inc., is $0.4857 per EA (NDC 00527551537), effective Feb 25, 2026.
How has the price of DEXTROAMP-AMPHET ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has declined 48.9%. It has been tracked across 280 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 30 MG CAP?
Since Oct 21, 2020, the NADAC for DEXTROAMP-AMPHET ER 30 MG CAP has ranged from a low of $0.3360 (May 22, 2024) to a high of $0.9501 (Nov 11, 2020), with a median of $0.6331 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 30 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 30 MG CAP, is $0.4689 per EA — about 3% below DEXTROAMP-AMPHET ER 30 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 30 MG CAP?
DEXTROAMP-AMPHET ER 30 MG CAP (NDC 00527551537) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.